tiprankstipranks
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP

Adaptimmune Therapeutics (ADAP) Technical Analysis

725 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Adaptimmune Therapeutics’s (ADAP) Moving Averages Convergence Divergence (MACD) indicator is 0.06, suggesting Adaptimmune Therapeutics is a Sell.
Adaptimmune Therapeutics’s (ADAP) 20-Day exponential moving average is 1.14, while Adaptimmune Therapeutics’s (ADAP) share price is $1.175, making it a Buy.
Adaptimmune Therapeutics’s (ADAP) 50-Day exponential moving average is 1.11, while Adaptimmune Therapeutics’s (ADAP) share price is $1.175, making it a Buy.

Adaptimmune Therapeutics (ADAP) Pivot Points

Jul 19, 2024, 08:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.14
1.19
1.22
1.27
1.30
1.35
1.38
Fibonacci
1.19
1.22
1.24
1.27
1.30
1.32
1.35
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Adaptimmune Therapeutics (ADAP) Moving Averages

Jul 19, 2024, 08:46 PM
Period
Simple
Exponential
MA5
1.25Sell
1.22Sell
MA10
1.22Sell
1.20Sell
MA20
1.08Buy
1.14Buy
MA50
1.07Buy
1.11Buy
MA100
1.21Sell
1.10Buy
MA200
0.97Buy
0.97Buy
Adaptimmune Therapeutics’s (ADAP) 10-Day exponential moving average is 1.20, while Adaptimmune Therapeutics’s (ADAP) share price is $1.175, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) 100-Day exponential moving average is 1.10, while Adaptimmune Therapeutics’s (ADAP) share price is $1.175, making it a Buy.
Adaptimmune Therapeutics’s (ADAP) stock price is $1.175 and Adaptimmune Therapeutics’s (ADAP) 50-day simple moving average is 1.07, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $1.175 and Adaptimmune Therapeutics’s (ADAP) 100-day simple moving average is 1.21, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $1.175 and Adaptimmune Therapeutics’s (ADAP) 200-day simple moving average is 0.97, creating a Buy signal.

Adaptimmune Therapeutics (ADAP) Technical Indicators

Jul 19, 2024, 08:46 PM
Name
Value
Implied Action
RSI (14)
55.28
Neutral
STOCH (9,6)
59.40
Neutral
STOCHRSI (14)
71.65
Neutral
MACD (12,26)
0.06
Sell
ADX (14)
22.36
Neutral
Williams %R
-46.34
Buy
CCI (14)
61.93
Neutral
ATR (14)
0.10
-
Ultimate Oscillator
49.24
Neutral
ROC
20.41
Buy
Adaptimmune Therapeutics’s (ADAP) Relative Strength Index (RSI) is 55.28, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Trend Strength Indicator (ADX) is 22.36, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Commodity Channel Index (CCI) is 61.93, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Price Rate of Change (ROC) is 20.41, creating a Buy signal.

FAQ

Is ADAP a Buy, Hold, or Sell?
Based on ADAP’s technical indicators, ADAP is a Buy.
    What is ADAP’s RSI (14)?
    ADAP’s RSI (14) is 55.28, which suggests ADAP is a Neutral.
      What is ADAP’s MACD?
      ADAP’s MACD is 0.06, which suggests ADAP is a Sell.
        What is ADAP’s 5-day moving average?
        ADAP’s 5-day moving average is 1.25, which suggests ADAP is a Sell.
          What is ADAP’s 20-day moving average?
          ADAP 20-day moving average is 1.08, which suggests ADAP is a Buy.
            What is ADAP’s 50-day moving average?
            ADAP’s 50-day moving average is 1.07, which suggests ADAP is a Buy.
              What is ADAP’s 200-day moving average?
              ADAP’s 200-day moving average is 0.97, which suggests ADAP is a Buy.
                What is ADAP’s Williams % R (14)?
                ADAP’s Williams % R (14) is -46.34, which suggests ADAP is a Buy.
                  What is ADAP’s CCI (14)?
                  ADAP’s CCI (14) is 61.93, which suggests ADAP is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis